Cargando…

Use of Vivostat PRF® in Acanthamoeba keratitis

We present a case of a 27-year-old contact lens male user who was diagnosed with Acanthamoeba keratitis. Given the inefficiency of medical treatment and high risk of corneal perforation, we decided to use Vivostat PRF®, with satisfactory results. To our knowledge, this is the first described case in...

Descripción completa

Detalles Bibliográficos
Autores principales: Marín-Payá, Emma, Rahhal-Ortuño, Miriam, Aguilar-González, Marina, Fernández-Santodomingo, Alex Samir, García-Delpech, Salvador
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Romanian Society of Ophthalmology 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7339696/
https://www.ncbi.nlm.nih.gov/pubmed/32685791
_version_ 1783554936098783232
author Marín-Payá, Emma
Rahhal-Ortuño, Miriam
Aguilar-González, Marina
Fernández-Santodomingo, Alex Samir
García-Delpech, Salvador
author_facet Marín-Payá, Emma
Rahhal-Ortuño, Miriam
Aguilar-González, Marina
Fernández-Santodomingo, Alex Samir
García-Delpech, Salvador
author_sort Marín-Payá, Emma
collection PubMed
description We present a case of a 27-year-old contact lens male user who was diagnosed with Acanthamoeba keratitis. Given the inefficiency of medical treatment and high risk of corneal perforation, we decided to use Vivostat PRF®, with satisfactory results. To our knowledge, this is the first described case in medical literature in which Vivostat PRF® is used as part of Acanthamoeba keratitis treatment.
format Online
Article
Text
id pubmed-7339696
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Romanian Society of Ophthalmology
record_format MEDLINE/PubMed
spelling pubmed-73396962020-07-17 Use of Vivostat PRF® in Acanthamoeba keratitis Marín-Payá, Emma Rahhal-Ortuño, Miriam Aguilar-González, Marina Fernández-Santodomingo, Alex Samir García-Delpech, Salvador Rom J Ophthalmol Case Reports We present a case of a 27-year-old contact lens male user who was diagnosed with Acanthamoeba keratitis. Given the inefficiency of medical treatment and high risk of corneal perforation, we decided to use Vivostat PRF®, with satisfactory results. To our knowledge, this is the first described case in medical literature in which Vivostat PRF® is used as part of Acanthamoeba keratitis treatment. Romanian Society of Ophthalmology 2020 /pmc/articles/PMC7339696/ /pubmed/32685791 Text en ©Romanian Society of Ophthalmology http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Marín-Payá, Emma
Rahhal-Ortuño, Miriam
Aguilar-González, Marina
Fernández-Santodomingo, Alex Samir
García-Delpech, Salvador
Use of Vivostat PRF® in Acanthamoeba keratitis
title Use of Vivostat PRF® in Acanthamoeba keratitis
title_full Use of Vivostat PRF® in Acanthamoeba keratitis
title_fullStr Use of Vivostat PRF® in Acanthamoeba keratitis
title_full_unstemmed Use of Vivostat PRF® in Acanthamoeba keratitis
title_short Use of Vivostat PRF® in Acanthamoeba keratitis
title_sort use of vivostat prf® in acanthamoeba keratitis
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7339696/
https://www.ncbi.nlm.nih.gov/pubmed/32685791
work_keys_str_mv AT marinpayaemma useofvivostatprfinacanthamoebakeratitis
AT rahhalortunomiriam useofvivostatprfinacanthamoebakeratitis
AT aguilargonzalezmarina useofvivostatprfinacanthamoebakeratitis
AT fernandezsantodomingoalexsamir useofvivostatprfinacanthamoebakeratitis
AT garciadelpechsalvador useofvivostatprfinacanthamoebakeratitis